CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

Positive
AI Analysis

Summary

Emerald Clinical Trials announced the appointment of Michael Stibilj as Chief Executive Officer, effective October 1, 2026, to lead the company's next phase of global growth.

Importance:2/10
Sentiment:
0.30
managementCEO appointmentleadership change
Related Companies

Read the original article

Published by PR Newswire Biotech on October 1, 2026 3:00 AM

Read Original